Real-World study asks: does this HS drug ease the pain and smell?

NCT ID NCT06444087

Ongoing Symptom relief Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how patients with hidradenitis suppurativa (HS) feel their symptoms change over time after starting the medication secukinumab. It will follow 192 adults in France for up to two years, focusing on their personal ratings of pain, skin drainage, and odor. The goal is to gather real-world information on whether and how this treatment improves daily life for people with HS.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Nice, France, 06000, France
Novartis Investigative Site

Antony, 92160, France
Novartis Investigative Site

Bordeaux, 33075, France
Novartis Investigative Site

Brest, 29609, France
Novartis Investigative Site

Calais, 62100, France
Novartis Investigative Site

Dijon, 21000, France
Novartis Investigative Site

La Rochelle, 17019, France
Novartis Investigative Site

Le Mans, 72000, France
Novartis Investigative Site

Lille, 59037, France
Novartis Investigative Site

Lorient, 56322, France
Novartis Investigative Site

Lyon, 69003, France
Novartis Investigative Site

Marseille, 13008, France
Novartis Investigative Site

Martigues, 13500, France
Novartis Investigative Site

Montpellier, 34090, France
Novartis Investigative Site

Nantes, 44093, France
Novartis Investigative Site

Paris, 75014, France
Novartis Investigative Site

Rodez, 12000, France
Novartis Investigative Site

Rouen, 76031, France
Novartis Investigative Site

Saint-Mandé, 94160, France
Novartis Investigative Site

Saint-Pierre, 97410, France
Novartis Investigative Site

Toulouse, 31400, France
Novartis Investigative Site

Vannes, 56000, France

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA